Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/183-bevacizumab-pemetrexed-and-cisplatin-or-erlotinib-and-bevacizumab-for-advanced-non-squamous-nsclc-stratified-by-egfr-mutation-status-a-multicenter-phase-ii-trial-including-biopsy-at-progression-bio-pro-trial/publications